Purpose This study sought to look for the maximum tolerated dose (MTD) of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma (HNSCC). related to treatment. Seven individuals were still alive having a median follow-up of 30 weeks (12C58 weeks). Nine individuals had a total response (CR) at 3 months after… Continue reading Purpose This study sought to look for the maximum tolerated dose